Plasma phospholipid trans fatty acids and risk of heart failure

American Journal of Clinical Nutrition

Volumn 97, Issue 4, 2013, Pages 698-705

  Tokede, Oluwabunmi A ^a   Petrone, Andrew B ^a   Hanson, Naomi Q ^b   Tsai, Michael Y ^c   Weir, Natalie A ^c   Glynn, Robert J ^a,d,f   Gaziano, J Michael ^a,e,f   Djoussé, Luc ^a,e,f,g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e and Clinicalx Center   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PHOSPHOLIPID; TRANS FATTY ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FATTY ACID BLOOD LEVEL; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; GAS CHROMATOGRAPHY; HEART FAILURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VALIDATION STUDY;

EID: 84875818783     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.050120     Document Type: Article

References (44)

1. Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood) 2007;26:13-24.
2. Reddy KS. Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutr 2002;5:231-7.
3. Braunwald E, Zipes DP, Libby P, Bonow R. Braunwald's heart disease: a textbook of cardiovascular medicine. 9th ed. Philadelphia, PA: Elsevier Saunders, 2004.
4. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D. Lifetime risk for developing congestive heart failure. Circulation 2002;106: 3068-72.
5. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50.
6. Roger VL, Go A, Lloyd-Jones D, Benjamin E, Berry J, Borden W, Bravata D, Dai S, Ford E, Fox C. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125:188-97.
7. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJJV. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002;4:361-71.
8. Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 1994;59:861-8.
9. Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC. trans Fatty acids and coronary heart disease. N Engl J Med 1999;340:1994-8.
10. Schulze MB, Hu FB. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health 2005;26: 445-67.
11. Kavanagh K, Jones KL, Sawyer J, Kelley K, Carr JJ, Wagner JD, Rudel LL. trans Fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity (Silver Spring) 2007;15:1675-84.
12. Proctor S. Nutrition bites: trans fats, dyslipidemia and the metabolic syndrome: are we missing the cream? Can Nurse 2007;103:10.
13. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, et al. Heart Disease and Stroke Statistics-2011 Update. Circulation 2011;123:e18-e209.
14. van Dam RM, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 2002;136:201-9.
15. Meyer KA, Kushi L, Jacobs D Jr, Folsom A. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001;24:1528-35.
16. van de Vijver LP, van Poppel G, van Houwelingen A, Kruyssen D, Hornstra G. trans Unsaturated fatty acids in plasma phospholipids and coronary heart disease: a case-control study. Atherosclerosis 1996;126: 155-61.
17. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-35.
18. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JAE, Glynn RJ, Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized trial. JAMA 2008;300:2123-33.
19. Djoussé L, Wilk JB, Hanson NQ, Glynn RJ, Tsai MY, Gaziano JM. Association between adiponectin and heart failure risk in the Physicians' Health Study. Obesity (Silver Spring) 2012.
20. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.
21. Djoussé L, Gaziano JM. Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation 2007;115:34-9.
22. Rose G. Cardiovascular survey methods. Geneva, Switzerland: WHO, 1982.
23. Cao J, Schwichtenberg K, Hanson N, Tsai M. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006;52:2265-72.
24. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122: 51-65.
25. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999;149:531-40.
26. Saadatian-Elahi M, Slimani N, Chajès V, Jenab M, Goudable J, Biessy C, Ferrari P, Byrnes G, Autier P, Peeters PHM. Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2009;89:331-46.
27. Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, Gibson RA, Giles GG. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007;86:189-97.
28. Lemaitre RN, King IB, Raghunathan TE, Pearce RM, Weinmann S, Knopp RH, Copass MK, Cobb LA, Siscovick DS. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 2002;105:697-701.
29. Lemaitre RN, King IB, Mozaffarian D, Sotoodehnia N, Rea TD, Kuller LH, Tracy RP, Siscovick DS. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults. Circulation 2006;114:209-15.
30. Rennison JH, McElfresh TA, Okere IC, Patel HV, Foster AB, Patel KK, Stoll MS, Minkler PE, Fujioka H, Hoit BD, et al. Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc Res 2008;79:331-40.
31. Galvao TF, Brown BH, Hecker PA, O'Connell KA, O'Shea KM, Sabbah HN, Rastogi S, Daneault C, Des Rosiers C, Stanley WC. High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects. Cardiovasc Res 2012;93:24-32.
32. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009;169:659-69.
33. Vardavas CI, Linardakis MK, Hatzis CM, Saris WHM, Kafatos AG. Cardiovascular disease risk factors and dietary habits of farmers from Crete 45 years after the first description of the Mediterranean diet. Eur J Cardiovasc Prev Rehabil 2010;17:440-6.
34. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B. Summary of American Heart Association diet and lifestyle recommendations revision 2006. Arterioscler Thromb Vasc Biol 2006;26:2186-91.
35. Clarke R, Emberson JR, Parish S, Palmer A, Shipley M, Linksted P, Sherliker P, Clark S, Armitage J, Fletcher A. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men. Arch Intern Med 2007;167:1373-8.
36. Salmerón J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willett WC. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001;73:1019-26.
37. van de Vijver LP, Kardinaal A, Couet C, Aro A, Kafatos A, Steingrimsdottir L, Amorim CJA, Moreiras O, Becker W, van Amelsvoort J. Association between trans fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study. Eur J Clin Nutr 2000;54:126-35.
38. Gebauer SK, Chardigny J-M, Jakobsen MU, Lamarche B, Lock AL, Proctor SD, Baer DJ. Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Adv Nutr 2011;2:332-54.
39. Emken EA. Nutrition and biochemistry of trans and positional fatty acid isomers in hydrogenated oils. Annu Rev Nutr 1984;4:339-76.
40. Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 2006;1:420-39.
41. Micha R, King IB, Lemaitre RN, Rimm EB, Sacks F, Song X, Siscovick DS, Mozaffarian D. Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr 2010;91:883-93.
42. Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D, Virtamo J. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997;145: 876-87.
43. Ascherio A, Rimm E, Giovannucci E, Spiegelman D, Stampfer M, Willett W. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 1996;313:84-90.
44. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997;337:1491-9.